Profile data is unavailable for this security.
About the company
Ansell Limited is an Australia-based safety solutions and an integrated manufacturer of personal protection equipment for healthcare and industrial workplaces. The Company is engaged in designing, developing, and manufacturing a wide range of hand, arm and body protection solutions and clothing. The Company operates through two segments: Healthcare Global Business Unit (GBU), and Industrial GBU. The Healthcare GBU segment is consists of surgical and examination gloves, healthcare safety devices and active infection prevention products for healthcare professionals and patients and single use industrial application gloves. The Industrial GBU segment comprises multi-use hand and body protection solutions for industrial worker environments and specialty applications. It provides protection solutions to approximately 25 specific industries and protects approximately 10 million workers each day. It serves various sectors including automotive, chemical, energy, healthcare, and others.
- Revenue in AUD (TTM)2.44bn
- Net income in AUD157.80m
- Incorporated1920
- Employees14.41k
- LocationAnsell LtdLevel 3, 678 Victoria StRICHMOND 3121AustraliaAUS
- Phone+61 39270-7270
- Fax+61 39270-7300
- Websitehttps://www.ansell.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shanghai MicroPort MedBot Group Co Ltd | 21.88m | -211.72m | 2.94bn | 650.00 | -- | 27.01 | -- | 134.16 | -1.14 | -1.14 | 0.1181 | 0.5864 | 0.0623 | 0.3746 | 42.10 | 174,117.10 | -60.96 | -- | -86.19 | -- | 14.05 | -- | -978.59 | -- | 0.8238 | -11.04 | 0.5427 | -- | 384.16 | -- | 11.20 | -- | -- | -- |
Micro-Tech Nanjing Co Ltd | 519.07m | 110.43m | 2.95bn | 2.40k | 26.69 | 3.78 | -- | 5.68 | 2.81 | 2.81 | 13.23 | 19.86 | 0.5948 | 1.62 | 6.91 | 1,032,216.00 | 12.91 | 10.74 | 14.98 | 12.82 | 64.81 | 63.04 | 21.71 | 19.37 | 5.19 | -- | 0.01 | 35.43 | 21.78 | 21.20 | 46.99 | 20.32 | 39.33 | -- |
Shanghai Haohai Biological Technology | 551.16m | 87.04m | 3.08bn | 2.16k | 16.17 | 1.17 | 24.11 | 5.58 | 2.64 | 2.64 | 16.72 | 36.59 | 0.3765 | 1.55 | 7.50 | 1,321,207.00 | 5.89 | 4.84 | 6.86 | 5.50 | 70.34 | 72.09 | 15.65 | 16.50 | 4.50 | -- | 0.0635 | 36.86 | 25.27 | 11.26 | 130.58 | 0.0762 | 11.96 | 14.27 |
Hartalega Holdings Berhad | 581.61m | -102.68m | 3.16bn | 7.56k | -- | 2.13 | -- | 5.43 | -0.0943 | -0.0943 | 0.5341 | 1.36 | 0.3316 | -- | 10.54 | 241,379.70 | -5.95 | 28.94 | -6.42 | 34.00 | -- | 46.86 | -17.94 | 29.87 | 4.84 | -37.13 | 0.0226 | 46.64 | -69.45 | 0.0331 | -107.27 | -- | 3.11 | -- |
Shanghai MicroPort Edvcl MdTch Grp CoLtd | 263.50m | 115.44m | 3.34bn | 908.00 | 26.39 | 3.95 | -- | 12.67 | 7.31 | 7.31 | 16.80 | 48.87 | 0.3769 | 1.60 | 7.96 | 1,387,329.00 | 16.35 | 17.68 | 18.12 | 19.43 | 75.61 | 76.60 | 43.39 | 42.25 | 9.49 | -- | 0.008 | 44.46 | 32.43 | 38.72 | 37.98 | 40.28 | 50.18 | -- |
Eyebright Medical Tchnlgy Beijing Co Ltd | 224.20m | 68.71m | 3.37bn | 2.07k | 49.08 | 7.27 | -- | 15.02 | 3.12 | 3.12 | 10.16 | 21.05 | 0.4003 | 1.99 | 5.19 | 516,774.60 | 11.51 | 9.99 | 13.27 | 11.16 | 72.24 | 81.29 | 28.74 | 34.66 | 2.48 | -- | 0.1339 | 19.91 | 64.14 | 49.59 | 30.63 | 71.80 | 38.83 | -- |
Beijing Balance Medical Technolgy Co Ltd | 79.91m | 23.39m | 3.40bn | 473.00 | 146.81 | 13.48 | -- | 42.60 | 0.8115 | 0.8115 | 2.77 | 8.84 | 0.3061 | 1.06 | 5.72 | 807,636.20 | 8.16 | 8.06 | 8.48 | 8.40 | 89.40 | 89.41 | 26.67 | 30.02 | 9.77 | -- | 0.0094 | 69.19 | 25.57 | 27.35 | 21.09 | 28.10 | 125.94 | -- |
Ansell Ltd | 2.44bn | 157.80m | 3.58bn | 14.41k | 20.20 | 1.31 | 13.42 | 1.47 | 1.24 | 1.24 | 19.28 | 19.22 | 0.6312 | 1.84 | 8.15 | 169,245.00 | 4.13 | 6.60 | 4.96 | 7.89 | 37.99 | 37.83 | 6.55 | 9.50 | 0.9475 | 11.46 | 0.2418 | 42.17 | -15.21 | 2.13 | -6.55 | 4.31 | 8.02 | 0.8306 |
NIHON KOHDEN CORPORATION | 2.12bn | 157.17m | 3.70bn | 5.75k | 22.45 | 2.12 | 19.08 | 1.75 | 192.27 | 192.27 | 2,593.61 | 2,037.86 | 1.03 | 1.74 | 3.87 | 37,943,840.00 | 7.67 | 8.60 | 9.57 | 11.53 | 50.74 | 50.51 | 7.41 | 8.19 | 2.53 | -- | 0.0026 | 26.85 | 0.7186 | 3.46 | -26.99 | 13.33 | 20.02 | 11.75 |
Holder | Shares | % Held |
---|---|---|
Allan Gray (Pty) Ltd.as of 05 Oct 2023 | 23.89m | 18.99% |
State Street Global Advisors, Australia, Ltd.as of 12 Apr 2024 | 7.83m | 6.23% |
The Vanguard Group, Inc.as of 29 Dec 2023 | 6.67m | 5.30% |
Australian Retirement Trust Pty Ltd.as of 15 Dec 2023 | 6.31m | 5.02% |
Allan Gray Australia Pty Ltd.as of 31 Mar 2024 | 5.91m | 4.70% |
Dimensional Fund Advisors LPas of 04 Apr 2024 | 3.03m | 2.41% |
Vanguard Investments Australia Ltd.as of 31 Mar 2024 | 2.19m | 1.74% |
Harris Associates LPas of 31 Mar 2024 | 2.01m | 1.60% |
BlackRock Fund Advisorsas of 04 Apr 2024 | 1.46m | 1.16% |
Hermes Investment Management Ltd.as of 29 Feb 2024 | 1.35m | 1.07% |